Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
-
Tesaro (TSRO) PT Lowered to $80 at Cowen on 'Launch Metrics, New Breast Cancer Strategy'
-
Top 5 Best Performing Shorts for the Week Ended August 11th -S3 Partners
-
Tesaro (TSRO) PT Lowered to $125 at Cowen; 'PARPs Are Largely Undifferentiated'
-
No Issue with Tesaro (TSRO) Trial - Cowen
-
Zejula Launch Makes Imminent Takeover of Tesaro (TSRO) 'Less Likely' - Cowen
-
Cowen Reiterates Market Perform Rating and $145 PT on TESARO (TSRO) Following FDA Broad Label Approval For Niraparib
-
Tesaro (TSRO) PT Lowered to $145 at Cowen Following Release of Olaparib SOLO-2 Data
-
Cowen Starts Tesaro (TSRO) at Market Perform
-
Notable Analyst Rating Changes 3/2: (ALSN) (ROST) (HABT) Upgraded; (VRX) (JOY) (AWK) Downgraded
-
UPDATE: Trading Radar for 10/29: Aetna (AET), LinkedIn (LNKD), Baidu (BIDU), ConocoPhillips (COP), MGM Resorts (MGM), Deckers (DECK) Report
-
Trading Radar for 4/29: ExxonMobil (XOM), AIG (AIG), Visa (V), LinkedIn (LNKD), Mosaic (MOS) Report

